NYSE ARCA | ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities.
The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ATAI | ATAI Life Sciences BV | Healthcare | Biotechnology | 12.13% |
| RLMD | Relmada Therapeutics Inc | Healthcare | Biotechnology | 9.34% |
| CYBN | Cybin Inc | Healthcare | Biotechnology | 7.94% |
| MNMD | Mind Medicine Inc | Healthcare | Biotechnology | 7.44% |
| CMPS | Compass Pathways Plc | Healthcare | Medical Care Facilities | 6.67% |
| CYBN | Cybin Inc | Healthcare | Biotechnology | 6.23% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 5.79% |
| VTGN | VistaGen Therapeutics Inc | Healthcare | Biotechnology | 5.63% |
| DRUG | Bright Minds Biosciences Inc | Healthcare | Biotechnology | 5.58% |
| ANRO | Alto Neuroscience, Inc. | Healthcare | Biotechnology | 5.42% |
| TTTXX | BlackRock Liquidity Funds - Treasury Trust Fund | 5.27% | ||
| QNTM | Quantum BioPharma Ltd Ordinary Shares - Class B (Sub Voting) | 5.20% | ||
| GHRS | GH Research PLC | Healthcare | Biotechnology | 5.01% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.69% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.68% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.65% |
| NRXP | NRX Pharmaceuticals Inc | Healthcare | Biotechnology | 4.64% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.46% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.42% |
| STIM | Neuronetics Inc | Healthcare | Medical Devices | 4.39% |